First Breath: a digital program to reduce prenatal secondhand smoke exposure
Feasibility and Acceptability of a Digital Intervention Program Aiming to Reduce Secondhand Smoke Exposure in Pregnancy: a Pilot Study
This pilot tests the First Breath app with pregnant women and their smoking partners to help reduce secondhand smoke exposure at home and in the car.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hebrew University of Jerusalem Academic / other |
| Locations | 1 site (Jerusalem) |
| Trial ID | NCT07003282 on ClinicalTrials.gov |
What this trial studies
This pilot enrolls pregnant women up to 24 weeks who do not smoke and their smoking partners to test a digital behavioral program called First Breath. Participants use the app, receive follow-up reminders, and pregnant women receive personal urine cotinine results as biochemical feedback. The program combines education on health risks, stepwise strategies to avoid exposure in the home and car, motivation-building, and advice about using nicotine-replacement therapy in the household. Feasibility and acceptability outcomes will be collected during follow-up to refine the intervention for larger trials.
Who should consider this trial
Good fit: Ideal candidates are pregnant, non-smoking women ≤24 weeks gestation who live with an adult partner who smokes daily and both can read Hebrew and access the internet.
Not a fit: Women with high-risk pregnancies, those without internet access, or couples whose smoking partner is already enrolled in a cessation program are unlikely to receive benefit from this intervention.
Why it matters
Potential benefit: If successful, it could lower pregnant women's exposure to secondhand smoke and reduce related risks to fetal and maternal health.
How similar studies have performed: Similar partner-inclusive digital interventions and biomarker feedback approaches have shown promising results in reducing household secondhand smoke, but evidence specifically in prenatal populations remains limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Pregnant women: Inclusion criteria: 1. ≤24 gestational weeks; 2. at least 18 years old; 3. living with a partner who smokes (at least one combustible cigarette a day); d) ability to understand Hebrew at a reasonable level; e) currently not smoking any tobacco or nicotine product (to clarify, women who smoked in the past are eligible). Exclusion criteria: 1. women with high-risk pregnancies, 2. no access to internet, 3. her partner is currently involved in a smoking cessation process. Expectant fathers who smoke: Inclusion criteria: 1. male, 2. at least 18 years old, 3. able to understand Hebrew at a reasonable level, 4. smoking at least one combustible cigarette per day, 5. currently living with a pregnant spouse who does not smoke any tobacco or nicotine product and 6. the spouse is ≤24 gestational weeks . Note: expectant father who are current users of other tobacco products (such as electronic cigarettes) are also eligible as long as they smoke at least one combustible cigarette a day. Exclusion criteria: 1. currently engaged in a smoking cessation program, 2. no access to the internet.
Where this trial is running
Jerusalem
- Braun School of Public Health and Community Medicine, Hebrew University of Jerusalem — Jerusalem, Israel (Recruiting)
Study contacts
- Principal investigator: Yael Bar-Zeev, MD MPH PhD — Hebrew University of Jerusalem
- Study coordinator: Yael Bar Zeev, MD MPH PhD
- Email: Yael.Bar-Zeev@mail.huji.ac.il
- Phone: +972-58-6878941
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.